Arteriosclerosis and Thrombosis, Vol 12, 1063-1070, Copyright © 1992 by American Heart Association

ARTICLES

The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group

M Cortellaro, C Boschetti, E Cofrancesco, C Zanussi, M Catalano, G de Gaetano, L Gabrielli, B Lombardi, G Specchia and L Tavazzi

The Progetto Lombardo Atero-Trombosi (PLAT) Study was a prospective, multicenter, multidisciplinary study of the association among hemostatic variables, conventional risk factors, and atherothrombotic events in four groups of patients with preexisting vascular ischemic disease (335 myocardial infarction survivors, 123 patients with stable angina pectoris, 160 with transient ischemic attacks, and 335 with peripheral vascular disease). In the myocardial infarction group, univariate analysis showed that atherothrombotic events were associated with high fibrinogen (p = 0.001), factor VIII:C (p less than 0.001), and von Willebrand factor antigen (vWF:Ag) (p = 0.004) levels and with low high density lipoprotein cholesterol (p = 0.043), factor VII (p = 0.019), and protein C (p = 0.044) levels; multivariate analysis produced associations with high fibrinogen and factor VIII:C levels and low protein C levels. By both univariate and multivariate analysis, events in the angina pectoris group were associated with high vWF:Ag (p = 0.026) and leukocyte (p = 0.033) levels and the presence of carotid arterial stenosis (p = 0.063); associations with high leukocyte (p = 0.037) and factor VIII:C (p = 0.186) levels, family history (p = 0.031), and diabetes (p = 0.061) were also found in the group with transient ischemic attacks. In those with peripheral vascular disease, events were associated with Fontaine stage greater than or equal to IIB (p = 0.024), high factor VIII:C levels (p = 0.073), and low protein C (p = 0.028), fibrinogen (p = 0.030), antithrombin III (p = 0.054), and factor VII (p = 0.057) levels by univariate analysis and with Fontaine stage and low fibrinogen levels by multivariate analysis.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. O. Spiel, J. C. Gilbert, and B. Jilma Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes Circulation, March 18, 2008; 117(11): 1449 - 1459. [Abstract] [Full Text] [PDF]

				K. R. Viel, D. K. Machiah, D. M. Warren, M. Khachidze, A. Buil, K. Fernstrom, J. C. Souto, J. M. Peralta, T. Smith, J. Blangero, et al. A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels Blood, May 1, 2007; 109(9): 3713 - 3724. [Abstract] [Full Text] [PDF]

				H. J. Teede, F. S. Dalais, D. Kotsopoulos, B. P. McGrath, E. Malan, T. E. Gan, and R. E. Peverill Dietary Soy Containing Phytoestrogens Does Not Activate the Hemostatic System in Postmenopausal Women J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1936 - 1941. [Abstract] [Full Text] [PDF]

				G. Ricci, F. Cerneca, R. Simeone, C. Pozzobon, S. Guarnieri, A. Sartore, R. Pregazzi, and S. Guaschino Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial Hum. Reprod., April 1, 2004; 19(4): 838 - 848. [Abstract] [Full Text] [PDF]

				L. E. Rabbani, N. A. Seminario, R. R. Sciacca, H. J. Chen, and E.-G. V. Giardina Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women J. Am. Coll. Cardiol., December 4, 2002; 40(11): 1991 - 1999. [Abstract] [Full Text] [PDF]

				V. Stangl, G. Baumann, and K. Stangl Coronary atherogenic risk factors in women Eur. Heart J., November 2, 2002; 23(22): 1738 - 1752. [Full Text] [PDF]

				J.D. Mills, M.W. Mansfield, and P.J. Grant Elevated fibrinogen in the healthy male relatives of patients with severe, premature coronary artery disease Eur. Heart J., August 2, 2002; 23(16): 1276 - 1281. [Abstract] [PDF]

				G. Theilmeier, C. Michiels, E. Spaepen, I. Vreys, D. Collen, J. Vermylen, and M. F. Hoylaerts Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia Blood, May 29, 2002; 99(12): 4486 - 4493. [Abstract] [Full Text] [PDF]

				A. Jager, V. W.M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 593 - 598. [Abstract] [Full Text] [PDF]

				J. B. Braunstein, D. W. Kershner, P. Bray, G. Gerstenblith, S. P. Schulman, W. S. Post, and R. S. Blumenthal Interaction of Hemostatic Genetics With Hormone Therapy : New Insights To Explain Arterial Thrombosis in Postmenopausal Women Chest, March 1, 2002; 121(3): 906 - 920. [Abstract] [Full Text] [PDF]

				P. Poredos State-of-the-Art Review: Endothelial Dysfunction in the Pathogenesis of Atherosclerosis Clinical and Applied Thrombosis/Hemostasis, October 1, 2001; 7(4): 276 - 280. [Abstract] [PDF]

				H. E. Gerritsen, R. Robles, B. Lammle, and M. Furlan Partial amino acid sequence of purified von Willebrand factor-cleaving protease Blood, September 15, 2001; 98(6): 1654 - 1661. [Abstract] [Full Text] [PDF]

				A. Sramek, J.H.C. Reiber, W.B.J. Gerrits, and F.R. Rosendaal Decreased Coagulability Has No Clinically Relevant Effect on Atherogenesis: Observations in Individuals With a Hereditary Bleeding Tendency Circulation, August 14, 2001; 104(7): 762 - 767. [Abstract] [Full Text] [PDF]

				P. Bogaty, P. Poirier, S. Simard, L. Boyer, S. Solymoss, and G. R. Dagenais Biological Profiles in Subjects With Recurrent Acute Coronary Events Compared With Subjects With Long-Standing Stable Angina Circulation, June 26, 2001; 103(25): 3062 - 3068. [Abstract] [Full Text] [PDF]

				D. F. Geffken, M. Cushman, G. L. Burke, J. F. Polak, P. A. Sakkinen, and R. P. Tracy Association between Physical Activity and Markers of Inflammation in a Healthy Elderly Population Am. J. Epidemiol., February 1, 2001; 153(3): 242 - 250. [Abstract] [Full Text] [PDF]

				D. Feng, G. H. Tofler, M. G. Larson, C. J. O’Donnell, I. Lipinska, C. Schmitz, P. A. Sutherland, M. T. Johnstone, J. E. Muller, R. B. D’Agostino, et al. Factor VII Gene Polymorphism, Factor VII Levels, and Prevalent Cardiovascular Disease : The Framingham Heart Study Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 593 - 600. [Abstract] [Full Text] [PDF]

				A. Jager, V. W. M. van Hinsbergh, P. J. Kostense, J. J. Emeis, J. S. Yudkin, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D. A. Stehouwer von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects : The Hoorn Study Arterioscler Thromb Vasc Biol, December 1, 1999; 19(12): 3071 - 3078. [Abstract] [Full Text] [PDF]

				G. Kenet, J. Freedman, B. Shenkman, E. Regina, F. Brok-Simoni, F. Holzman, F. Vavva, N. Brand, A. Michelson, M. Trolliet, et al. Plasma Glutathione Peroxidase Deficiency and Platelet Insensitivity to Nitric Oxide in Children With Familial Stroke Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 2017 - 2023. [Abstract] [Full Text] [PDF]

				M. Redondo, H. H. Watzke, B. Stucki, I. Sulzer, F. D. Biasiutti, B. R. Binder, M. Furlan, B. Lammle, and W. A. Wuillemin Coagulation Factors II, V, VII, and X, Prothrombin Gene 20210G->A Transition, and Factor V Leiden in Coronary Artery Disease : High Factor V Clotting Activity Is an Independent Risk Factor for Myocardial Infarction Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 1020 - 1025. [Abstract] [Full Text] [PDF]

				S. P. Wamala, M. A. Murray, M. Horsten, M. Eriksson, K. Schenck-Gustafsson, A. Hamsten, A. Silveira, and K. Orth-Gomer Socioeconomic Status and Determinants of Hemostatic Function in Healthy Women Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 485 - 492. [Abstract] [Full Text] [PDF]

				M. Eriksson, N. Egberg, S. Wamala, K. Orth-Gomer, M. A. Mittleman, and K. Schenck-Gustafsson Relationship Between Plasma Fibrinogen and Coronary Heart Disease in Women Arterioscler Thromb Vasc Biol, January 1, 1999; 19(1): 67 - 72. [Abstract] [Full Text] [PDF]

				A. M. Thogersen, J.-H. Jansson, K. Boman, T. K. Nilsson, L. Weinehall, F. Huhtasaari, and G. Hallmans High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women : Evidence for the Fibrinolytic System as an Independent Primary Risk Factor Circulation, November 24, 1998; 98(21): 2241 - 2247. [Abstract] [Full Text] [PDF]

				J-H Jansson, T K Nilsson, and O Johnson von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction Heart, October 1, 1998; 80(4): 334 - 337. [Abstract] [Full Text]

				D A Gorog, R Rakhit, D Parums, M Laffan, and G J Davies Raised factor VIII is associated with coronary thrombotic events Heart, October 1, 1998; 80(4): 415 - 417. [Abstract] [Full Text]

				P. M. Mannucci von Willebrand Factor : A Marker of Endothelial Damage? Arterioscler Thromb Vasc Biol, September 1, 1998; 18(9): 1359 - 1362. [Full Text] [PDF]

				L. Iacoviello, A. Di Castelnuovo, P. de Knijff, A. D'Orazio, C. Amore, R. Arboretti, C. Kluft, and M. B. Donati Polymorphisms in the Coagulation Factor VII Gene and the Risk of Myocardial Infarction N. Engl. J. Med., January 8, 1998; 338(2): 79 - 85. [Abstract] [Full Text] [PDF]

				W. F. Baker JR Thrombosis and Hemostasis in Cardiology: Review of Pathophysiology and Clinical Practice (Part I) Clinical and Applied Thrombosis/Hemostasis, January 1, 1998; 4(1): 51 - 75. [Abstract] [PDF]

				T. A. B. Sanders, F. R. Oakley, G. J. Miller, K. A. Mitropoulos, D. Crook, and M. F. Oliver Influence of n-6 versus n-3 Polyunsaturated Fatty Acids in Diets Low in Saturated Fatty Acids on Plasma Lipoproteins and Hemostatic Factors Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3449 - 3460. [Abstract] [Full Text]

				Z. Laszik, A. Mitro, F. B. Taylor Jr, G. Ferrell, and C. T. Esmon Human Protein C Receptor Is Present Primarily on Endothelium of Large Blood Vessels : Implications for the Control of the Protein C Pathway Circulation, November 18, 1997; 96(10): 3633 - 3640. [Abstract] [Full Text]

				J.-H. Jansson, K. Boman, M. Brannstrom, and T. K. Nilsson High Concentration of Thrombomodulin in Plasma Is Associated With Hemorrhage : A Prospective Study in Patients Receiving Long-term Anticoagulant Treatment Circulation, November 4, 1997; 96(9): 2938 - 2943. [Abstract] [Full Text]

				M. Tschopl, D. A. Tsakiris, G. A. Marbet, K.-H. Labs, and K. Jager Role of Hemostatic Risk Factors for Restenosis in Peripheral Arterial Occlusive Disease After Transluminal Angioplasty Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3208 - 3214. [Abstract] [Full Text]

				R. A. Hegele, W. C. Breckenridge, J. H. Brunt, and P. W. Connelly Genetic Variation in Factor VII Associated with Variation in Plasma Lipoprotein(a) Concentration Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1701 - 1706. [Abstract] [Full Text]

				F. J. Nieto, P. Sorlie, G. W. Comstock, K. Wu, E. Adam, J. L. Melnick, and M. Szklo Cytomegalovirus Infection, Lipoprotein(a), and Hypercoagulability: An Atherogenic Link? Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1780 - 1785. [Abstract] [Full Text]

				A. R. Folsom, K. K. Wu, W. D. Rosamond, A. R. Sharrett, and L. E. Chambless Prospective Study of Hemostatic Factors and Incidence of Coronary Heart Disease : The Atherosclerosis Risk in Communities (ARIC) Study Circulation, August 19, 1997; 96(4): 1102 - 1108. [Abstract] [Full Text]

				R. Junker, J. Heinrich, H. Schulte, J. van de Loo, and G. Assmann Coagulation Factor VII and the Risk of Coronary Heart Disease in Healthy Men Arterioscler Thromb Vasc Biol, August 1, 1997; 17(8): 1539 - 1544. [Abstract] [Full Text]

				M. W. Mansfield, D. M. Heywood, and P. J. Grant Circulating Levels of Factor VII, Fibrinogen, and von Willebrand Factor and Features of Insulin Resistance in First-Degree Relatives of Patients With NIDDM Circulation, November 1, 1996; 94(9): 2171 - 2176. [Abstract] [Full Text]

				M. Cushman, B. M. Psaty, E. Macy, E. G. Bovill, E. S. Cornell, L. H. Kuller, and R. P. Tracy Correlates of Thrombin Markers in an Elderly Cohort Free of Clinical Cardiovascular Disease Arterioscler Thromb Vasc Biol, September 1, 1996; 16(9): 1163 - 1169. [Abstract] [Full Text]

				J.G. van der Bom, M.L. Bots, H.H.D.M. van Vliet, H.A.P. Pols, A. Hofman, and D.E. Grobbee Antithrombin and Atherosclerosis in the Rotterdam Study Arterioscler Thromb Vasc Biol, July 1, 1996; 16(7): 864 - 867. [Abstract] [Full Text]

				S.G. Thompson, C. Fechtrup, E. Squire, U. Heyse, G. Breithardt, J.C.W. van de Loo, and J. Kienast Antithrombin III and Fibrinogen as Predictors of Cardiac Events in Patients With Angina Pectoris Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 357 - 362. [Abstract] [Full Text]

				M. Cortellaro, D. Baldassarre, E. Cofrancesco, E. Tremoli, A. Colombo, C. Boschetti, and R. Paoletti Relation Between Hemostatic Variables and Increase of Common Carotid Intima-Media Thickness in Patients With Peripheral Arterial Disease Stroke, March 1, 1996; 27(3): 450 - 454. [Abstract] [Full Text]

				R. P. Tracy, E. G. Bovill, D. Yanez, B. M. Psaty, L. P. Fried, G. Heiss, M. Lee, J. F. Polak, and P. J. Savage Fibrinogen and Factor VIII, but Not Factor VII, Are Associated With Measures of Subclinical Cardiovascular Disease in the Elderly : Results From the Cardiovascular Health Study Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1269 - 1279. [Abstract] [Full Text]

				T. Murakami, Y. Komiyama, M. Masuda, M. Karakawa, T. Iwasaka, and H. Takahashi Evaluation of Factor XIa–{alpha}1-Antitrypsin in Plasma, a Contact Phase–Activated Coagulation Factor–Inhibitor Complex, in Patients With Coronary Artery Disease Arterioscler Thromb Vasc Biol, August 1, 1995; 15(8): 1107 - 1113. [Abstract] [Full Text]

				S. G. Thompson, J. Kienast, S. D.M. Pyke, F. Haverkate, J. C.W. van de Loo, and The European Concerted Action on Thrombosis and Di Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris N. Engl. J. Med., March 9, 1995; 332(10): 635 - 641. [Abstract] [Full Text] [PDF]

				A. Jager, V. W.M. van Hinsbergh, P. J. Kostense, J. J. Emeis, G. Nijpels, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer C-Reactive Protein and Soluble Vascular Cell Adhesion Molecule-1 Are Associated With Elevated Urinary Albumin Excretion but Do Not Explain Its Link With Cardiovascular Risk Arterioscler Thromb Vasc Biol, April 1, 2002; 22(4): 593 - 598. [Abstract] [Full Text] [PDF]